510(k) Report

510(k) · Cleared

Cleared

XSense Cryoablation System with Cryoprobes

K240892510(k) TraditionalCleared Jun 28, 202488-day reviewClass II21 CFR 878.4350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

IceCure Medical, Ltd. · GEH Unit, Cryosurgical, Accessories

Cleared on Jun 28, 2024 as substantially equivalent to K183213 (IceCure Medical, Ltd., 2019) after an 88-day review. Its family tree reaches back 9 generations to 2001. 2 later devices descend from it.

Decided
Jun 28, 2024
Review
88 days
Class
Class II
Product code
GEH
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K003811 (2001). 21 ancestors in all, the oldest K790187 (1979). 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2007: 1 other ancestor1998: 1 other ancestor1997: 4 other ancestors1995: 1 other ancestor1984: 1 other ancestor2001: 1 other ancestor1990: 1 other ancestor1979: 1 other ancestor2026: 1 descendant cleared2025: 1 descendant cleared×4: 4 generations cleared close together, K003811 (2001), K020605 (2002), K021211 (2002), K022314 (2002) K052861 · Modification to:Sanarus Visica Treatment System , Models VS2000 · Sanarus Medical, Inc. · 2005×2: 2 generations cleared close together, K061510 (2006), K062896 (2007) K102360 · Icesence 3 · IceCure Medical, Ltd. · 2010 · recalledK183213 · IceSense 3, ProSense, MultiSense · IceCure Medical, Ltd. · 201919801990200020102020
  1. Root · 9 generations backK003811 Cryocare Surgical SystemEndocare, Inc. · 2001
  2. 5 generations between
  3. 3 generations backK062896 V2 Treatment System (V2 Console, V2 Ice Probe, V2 Dewars) Models…Sanarus Medical, Inc. · 2007
  4. 2 generations backK102360 Icesence 3IceCure Medical, Ltd. · 2010 · Recalled
  5. 1 generation backK183213 IceSense 3, ProSense, MultiSenseIceCure Medical, Ltd. · 2019
  6. This deviceK240892 XSense Cryoablation System with CryoprobesIceCure Medical, Ltd. · 2024
  7. Descendant · cites it directly · 0 of its ownK260377 XSense Cryoablation System with CryoProbesIceCure Medical, Ltd. · 2026
  8. Descendant · cites it directly · 0 of its ownK243042 Co-Ablation System with Sterile Co-Ablation ProbeHygea Medical Technology Co., Ltd. · 2025
Show all 9 generations
  1. Root · 9 generations backK003811 Cryocare Surgical SystemEndocare, Inc. · 2001
  2. 8 generations backK020605 Sanarus Visica Treatment SystemSanarus Medical, Inc. · 2002
  3. 7 generations backK021211 Modification to Sanarus Visica Treatment SystemSanarus Medical, Inc. · 2002
  4. 6 generations backK022314 Sanarus Visica Treatment SystemSanarus Medical, Inc. · 2002 · Recalled
  5. 5 generations backK052861 Modification to:Sanarus Visica Treatment System , Models VS2000Sanarus Medical, Inc. · 2005
  6. 4 generations backK061510 Sanarus Visica Treatment SystemSanarus Medical, Inc. · 2006
  7. 3 generations backK062896 V2 Treatment System (V2 Console, V2 Ice Probe, V2 Dewars) Models…Sanarus Medical, Inc. · 2007
  8. 2 generations backK102360 Icesence 3IceCure Medical, Ltd. · 2010 · Recalled
  9. 1 generation backK183213 IceSense 3, ProSense, MultiSenseIceCure Medical, Ltd. · 2019
  10. This deviceK240892 XSense Cryoablation System with CryoprobesIceCure Medical, Ltd. · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K260377XSense Cryoablation System with CryoProbesIceCure Medical, Ltd. · 2026 · cites it directly0descendants
  • K243042Co-Ablation System with Sterile Co-Ablation ProbeHygea Medical Technology Co., Ltd. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K003811Cryocare Surgical SystemEndocare, Inc.2001—
−8K020605Sanarus Visica Treatment SystemSanarus Medical, Inc.2002—
−7K021211Modification to Sanarus Visica Treatment SystemSanarus Medical, Inc.2002—
−6K022314Sanarus Visica Treatment SystemSanarus Medical, Inc.20021
−5K052861Modification to:Sanarus Visica Treatment System , Models VS2000Sanarus Medical, Inc.2005—
−4K061510Sanarus Visica Treatment SystemSanarus Medical, Inc.2006—
−3K062896V2 Treatment System (V2 Console, V2 Ice Probe, V2 Dewars) Models; VS3000…Sanarus Medical, Inc.2007—
−2K102360Icesence 3IceCure Medical, Ltd.20101
−1K183213IceSense 3, ProSense, MultiSenseIceCure Medical, Ltd.2019—
0 (this device)K240892XSense Cryoablation System with CryoprobesIceCure Medical, Ltd.2024—
+1K260377XSense Cryoablation System with CryoProbesIceCure Medical, Ltd.2026—
+1K243042Co-Ablation System with Sterile Co-Ablation ProbeHygea Medical Technology Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
197910
198410
199010
199510
199740
199810
200110
200510
200710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202610
FIG. 1 — Lineage of K240892, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEH device

  1. #1 K211099 Freeze’n Clear Skin Clinic Warts & Tagsscore 25.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K183213IceSense 3, ProSense, MultiSense
Summary page 6
…ablation System which was cleared as part of IceCure Family Cryoablation System (IceSense™3, ProSense™, and MultiSense™) (K183213) Intended Use/Indication for Use: XSense Cryoablation System with CryoProbes is intended for cryogenic destruction of tissue…
IceCure Medical, Ltd.2019—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260377XSense Cryoablation System with CryoProbesIceCure Medical, Ltd.20260
K243042Co-Ablation System with Sterile Co-Ablation ProbeHygea Medical Technology Co., Ltd.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 8 months on median.
  • 2 of the 21 ancestors have a recall of any class.
  • Of its descendants, K260377 (IceCure Medical, Ltd., 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All GEH devices

GEH Unit, Cryosurgical, Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · GEH

10in 2025

2007: 62008: 12009: 42010: 42011: 72012: 42013: 42014: 62015: 112016: 152017: 122018: 62019: 62020: 82021: 62022: 62023: 82024: 92025: 102026 (partial year): 8
2007high 15 (2016) · low 1 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEH

77in 2025

2007: 71 days median2009: 121 days median2010: 86 days median2011: 91 days median2012: 96 days median2013: 76 days median2014: 42 days median2015: 72 days median2016: 60 days median2017: 83 days median2018: 42 days median2019: 115 days median2020: 113 days median2021: 206 days median2022: 56 days median2023: 136 days median2024: 85 days median2025: 77 days median2026 (partial year): 148 days median
2007high 206 (2021) · low 42 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEH

2in 2023

2007: 32008: 22009: 132010: 42012: 32014: 22018: 12019: 12020: 372023: 22026 (partial year): 2
2007high 37 (2020) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GEH

171in 2025

2007: 232008: 292009: 212010: 1732011: 612012: 912013: 912014: 572015: 972016: 1432017: 2162018: 2082019: 4552020: 2772021: 2132022: 2302023: 1642024: 1412025: 171
2007high 455 (2019) · low 21 (2009)2025

MAUDE reports naming product code GEH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007671323
20081—229
200941211321
20104864173
2011791061
2012496391
2013476091
2014642257
20151172097
201615600143
201712830216
20186421208
201961151455
2020811337277
202162060213
20226560230
202381362164
20249850141
202510770171
202681482—

What is it indicated for?

XSense Cryoablation System with CryoProbes is intended for cryogenic destruction of tissue during surgical procedures by the application of extreme cold temperatures. XSense Cryoablation System with CryoProbes is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology. The system is designed to destroy tissue by the…

Read the full statement (311 words)

XSense Cryoablation System with CryoProbes is intended for cryogenic destruction of tissue during surgical procedures by the application of extreme cold temperatures.

XSense Cryoablation System with CryoProbes is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery, ENT, gynecology, oncology, proctology, and urology.

The system is designed to destroy tissue by the application of extreme cold temperatures including fibroadenomas, prostate and kidney tissue, liver metastases, tumors, skin lesions, and warts.

XSense Cryoablation System with CryoProbes may be used with an imaging device such as an ultrasound to provide real-time visualization of the cryosurgical procedure.

The system has the following specific indications:

• Urology - Ablate prostate tissue in cases of prostate cancer and benign prostatic hyperplasia (BPH).

• Oncology - Ablation of cancerous or malignant tissue and benign tumors and palliative intervention.

• Dermatology - Ablation or freezing of skin cancers and other cutaneous disorders. Palliation of tumors of the skin. Destruction of warts or lesions.

• Gynecology - Ablation of malignant neoplasia or benign dysplasia of the female genitalia.

• ENT (Ear, Nose, and Throat) - Palliation of tumors of the oral cavity and ablation of leukoplakia of the mouth.

• General Surgery - Ablation of breast fibroadenomas, leukoplakia of mouth, angiomas, sebaceous hyperplasia, basal cell tumors of the eyelid or canthus area, ulcerated basal cell tumors, dermatofibromas, small hemangiomas, mucocele cysts, multiple warts, plantar warts, hemorrhoids, anal fissures, perianal condylomata, pilonidal cysts actinic and seborrheic keratoses, cavernous hemangiomas, recurrent cancerous lesions. Palliation of tumors of the rectum, hemorrhoids, anal fissures, pilonidal cysts, and recurrent cancerous lesions. Destruction of warts or lesions. Palliation of tumors of the oral cavity, rectum, and skin.

• Thoracic Surgery - Ablation of arrhythmic cardiac tissue and cancerous lesions.

• Proctology - Ablation of benign or malignant growths of the anus and rectum and hemorrhoids.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240892: XSense Cryoablation System with Cryoprobes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K240892

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026